AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 112 min read$CLRO

CLEARONE INC (CLRO): Entry into a Material Definitive Agreement

CLEARONE INC (CLRO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.4 10 ex104_4.htm EXHIBIT 10.4 Exhibit 10.4 ADVISOR AGREEMENT This Advisor Agreement (this “ Agreement ”) is made and entered into as of August 7 , 2026 by and between ClearOne, Inc. , a Nevada company (the “ Company ”), and JJK Holdings Ltd. , (“ Advisor ”) (each herein ref

Original reporting
SEC EDGAR 8-K
Published Aug 11, 2026, 9:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$CLRO
Neutral
low confidence
Mentioned
$CLRO
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLRONeutralLow
01

Why it matters

This is a corporate contracting disclosure. The excerpt emphasizes confidentiality, IP assignment, and termination mechanics, but does not include the compensation or specific services in Exhibit A.

02

Market read

The filing is new and primary-source, but the provided text lacks the economic terms that would typically drive a tradable repricing.

03

What to watch

Traders should check the full 8-K for Exhibit A details (fees, term, termination triggers) and whether the advisor role relates to sales, regulatory, or restructuring efforts.

Relevance 6/10Novelty 4/10Timing: filed Aug 11, 2026 (after market)

Background

The SEC 8-K reports Item 1.01, entry into a material definitive agreement, attaching an advisor agreement between ClearOne and JJK Holdings Ltd.

Company-level read

Ticker impact

$CLRONeutralLow confidence
Context

ClearOne entered a material definitive agreement, disclosing an advisor agreement with JJK Holdings Ltd. as an independent contractor.

Expected impact

Likely limited immediate impact unless the omitted Exhibit A compensation or scope is material.

Evidence & confidence

The filing is primary-source and time-stamped, but the provided text is mostly boilerplate confidentiality and IP terms, with no disclosed fees, duration, or expected outcomes.

Market effects

Sector

Minimal, as this appears to be an advisory services engagement rather than a product, regulatory, or financial restructuring event.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

If Exhibit A compensation or deliverables are substantial, the market may re-rate the cost structure or signal a strategic initiative not visible in the excerpt.

Key entities

  • issuer
    ClearOne, Inc.

    Subject of the 8-K, entered into an advisor agreement and disclosed the terms via Exhibit 10.4.

  • advisor
    JJK Holdings Ltd.

    Counterparty to the advisor agreement providing advisory services as an independent contractor.

Read at source← All news

Related articles

AUG 6
$CLROMedAI 8/10

ClearOne (CLRO) Stock Soars Over 98% After Hours: Here's What You Need To Know ClearOne Shares Surge 98%

ClearOne (CLRO) shares jumped about 98% after hours after a majority stockholder, First Finance Ltd., approved by written consent the issuance of 12.5 million common shares tied to a merger, exceeding 20% of outstanding shares and triggering a change-of-control. The issuance takes effect 20 days after shareholder disclosure. ClearOne canceled First Finance warrants and signed CFO Simon Brewer to a new deal with $300,000 salary and 200,000 options.

benzinga.com3 min
JUL 2
$CLROHighAI 9/10

ClearOne Stock Surges 30% On Cortigent Merger Agreement

ClearOne, Inc. (CLRO) shares rose 30.41% to $4.19 on Thursday after the company said it signed a definitive merger agreement under which Vivani Medical’s subsidiary Cortigent will become a wholly owned ClearOne unit. ClearOne plans a $10m–$15m concurrent financing. Cortigent develops implantable neurostimulation technologies.

rttnews.com2 min
JUL 2
$CLROMedAI 8/10

ClearOne stock surges 50% on Vivani merger deal By Investing.com

ClearOne Inc (NASDAQ:CLRO) shares rose about 52.6% after it announced a definitive merger with Cortigent Inc, a Vivani Medical Inc (NASDAQ:VANI) subsidiary. Cortigent will become a wholly owned ClearOne unit; Vivani will receive 12.5M CLRO shares. Vivani would own 59.4%-67.5% post-close; ClearOne will rename Cortigent Holdings Inc, expected to trade as CRGT. An S-1 for $10M-$15M is planned; closing expected Q3 2026.

investing.com4 min
JUL 2
$VANIMedAI 8/10

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO), with Cortigent becoming a wholly owned ClearOne unit. ClearOne plans a concurrent $10–15M financing via an S-1. Vivani will receive 12.5M ClearOne shares for 59.4%–67.5% ownership; ClearOne will rename to Cortigent Holdings (CRGT), expected to close Q3 2026.

manilatimes.net7 min
JUL 2
$VANIMedAI 8/10

Vivani Medical, Inc.: Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO) via a definitive agreement, making Cortigent a wholly owned ClearOne unit. ClearOne plans a concurrent $10m–$15m financing. Vivani will receive 12.5m ClearOne shares and own 59.4%–67.5%; the combined company will trade as CRGT, expected to close Q3 2026.

finanznachrichten.de5 min